JPS59106492A - セフアロスポリン抗生物質 - Google Patents

セフアロスポリン抗生物質

Info

Publication number
JPS59106492A
JPS59106492A JP58218805A JP21880583A JPS59106492A JP S59106492 A JPS59106492 A JP S59106492A JP 58218805 A JP58218805 A JP 58218805A JP 21880583 A JP21880583 A JP 21880583A JP S59106492 A JPS59106492 A JP S59106492A
Authority
JP
Japan
Prior art keywords
compound
group
formula
acid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58218805A
Other languages
English (en)
Japanese (ja)
Inventor
ブライアン・エドガ−・ルツカ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPS59106492A publication Critical patent/JPS59106492A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58218805A 1982-11-24 1983-11-22 セフアロスポリン抗生物質 Pending JPS59106492A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8233521 1982-11-24
GB8233521 1982-11-24

Publications (1)

Publication Number Publication Date
JPS59106492A true JPS59106492A (ja) 1984-06-20

Family

ID=10534479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58218805A Pending JPS59106492A (ja) 1982-11-24 1983-11-22 セフアロスポリン抗生物質

Country Status (18)

Country Link
JP (1) JPS59106492A (fr)
KR (1) KR840006811A (fr)
AU (1) AU2161783A (fr)
BE (1) BE898293A (fr)
DE (1) DE3342317A1 (fr)
DK (1) DK535083A (fr)
FI (1) FI834297A (fr)
FR (1) FR2536402A1 (fr)
GB (1) GB2132193B (fr)
GR (1) GR79078B (fr)
IL (1) IL70310A0 (fr)
IT (1) IT1175800B (fr)
LU (1) LU85101A1 (fr)
NL (1) NL8304024A (fr)
NO (1) NO834304L (fr)
PT (1) PT77711B (fr)
SE (1) SE8306475L (fr)
ZA (1) ZA838733B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148004A3 (fr) * 1983-12-30 1986-04-23 Glaxo Group Limited Dérivés de céphalosporine antibiotiques
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
DK0449515T3 (da) * 1990-03-24 1995-10-16 Lucky Ltd Hidtil ukendte cephalosporin-mellemprodukter og fremgangsmåde til fremstilling af mellemprodukterne og slutprodukter deraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB2027691B (en) * 1978-05-26 1983-03-02 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
DK535083D0 (da) 1983-11-23
IT1175800B (it) 1987-07-15
NO834304L (no) 1984-05-25
ZA838733B (en) 1985-01-30
GB2132193A (en) 1984-07-04
LU85101A1 (fr) 1984-06-13
GB2132193B (en) 1985-12-18
AU2161783A (en) 1984-05-31
PT77711B (pt) 1986-03-27
FR2536402A1 (fr) 1984-05-25
SE8306475L (sv) 1984-05-25
FI834297A (fi) 1984-05-25
IT8349380A0 (it) 1983-11-23
DK535083A (da) 1984-05-25
GB8331292D0 (en) 1983-12-29
KR840006811A (ko) 1984-12-03
FI834297A0 (fi) 1983-11-23
GR79078B (fr) 1984-10-02
SE8306475D0 (sv) 1983-11-23
DE3342317A1 (de) 1984-05-24
IL70310A0 (en) 1984-02-29
BE898293A (fr) 1984-05-23
NL8304024A (nl) 1984-06-18
PT77711A (en) 1983-12-01

Similar Documents

Publication Publication Date Title
US4258041A (en) (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof
JPS6127921A (ja) セフアロスポリン化合物を有効成分とする薬学的組成物
SK280156B6 (sk) Cefalosporíny, ktoré majú v polohe 3 propenylový r
DK156900B (da) Analogifremgangsmaade til fremstilling af cephalosporinderivater
NO793688L (no) Fremgangsmaate ved fremstilling av cephalosporinderivater
GB2036724A (en) Cephalosporin compounds
US4315005A (en) Cephalosporin antibiotics
JPS59106492A (ja) セフアロスポリン抗生物質
JPH0633281B2 (ja) 新規セファロスポリン化合物及び抗菌剤
JPS6310792A (ja) 新規セフエム化合物
DE3784778T2 (de) Cephemverbindungen, ihre herstellung und anwendung.
EP0349340A2 (fr) Composé céphem, procédé pour sa préparation et composition antibactérienne
IE49099B1 (en) Cephalosporin compounds
JPS62209082A (ja) セフアロスポリン誘導体
CA1215355A (fr) Esters de cephalosporine, leur production et leur emploi
GB2046261A (en) Cephalosporin antibiotics
GB2037281A (en) 7-( alpha -(2-amino.4-thiazolyl)- alpha - hydroximino-acetamido)- cephalosporins
JPS58210093A (ja) セフアロスポリン抗生物質
KR0143534B1 (ko) 신규 세팔로스포린계 화합물과 그의 제조방법
GB2131800A (en) Cephalosporins
US4963542A (en) Cephalosporin derivatives
KR830001592B1 (ko) 세팔로스포린 항생제의 제조방법
CN101153044B (zh) 广谱抗菌的含有硫基噻唑吡啶鎓甲基的头孢烯化合物
GB2123415A (en) Cephalosporin antibiotics
GB2027692A (en) Cephalosporin Antibiotics